Vikas Sinha Net Worth & Insider Trades

Vikas Sinha - EVP & CFO, Alexion Pharmaceuticals Inc

As of August 10, 2016

What is Vikas Sinha's Net Worth?

The current estimated net worth of Alexion Pharmaceuticals Inc's EVP & CFO, Vikas Sinha, is estimated to be about $157.4M . Vikas Sinha owns about 178,463 units of Alexion Pharmaceuticals Inc common stock. In the last 11 years at Alexion Pharmaceuticals Inc, Vikas Sinha has sold an estimated value of $79.01M worth.

What is Vikas Sinha's Past Insider Trading?

Vikas Sinha's largest purchase order was 75,000 units , worth over $1.41M on December 4, 2014. Vikas Sinha's largest sale order was 75,000 units , worth over $14.92M on December 4, 2014. In total, Vikas Sinha has made about 75 transactions over 11 years of their time at Alexion Pharmaceuticals Inc. Vikas Sinha usually trades in January, with the busiest year in 2010. The most recent transaction was a sale order of 277 units , worth over $37.99K on August 10, 2016.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Vikas Sinha's Salary in 2020?

As EVP & CFO of Alexion Pharmaceuticals Inc, Vikas Sinha has a total base salary of $412,000 . Vikas Sinha received compensation valued at about $6,320,540 in 2020 after becoming EVP & CFO. The vast majority of their compensation came in the form of option awards of $5,665,640 , other earnings, plans or compensations of $238,960 , and other compensation of $3,940 .

What is Vikas Sinha's' Mailing Address?

  • Mailing address is C/o Alexion Pharmacueticals, Inc. 352 Knotter Drive Cheshire CT 06410 CT

Alexion Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ludwig Hantson 2019 $1,250,000 - $15,243,634 - $2,430,000 $24,350 $18,947,984
Ludwig Hantson 2018 $1,200,000 - $12,385,168 - $2,880,000 $25,082 $16,490,250
Ludwig Hantson 2017 $900,000 - $9,618,758 $2,282,881 $2,275,000 $233,428 $15,310,067
Aradhana Sarin 2019 $651,764 - $3,380,763 - $813,011 $31,604 $4,877,142
Paul Clancy 2019 $927,000 - $3,863,694 - $1,051,218 $23,832 $5,865,744
Paul Clancy 2018 $900,000 - $3,302,761 - $1,260,000 $23,752 $5,486,513
Paul Clancy 2017 $415,385 $500,000 $8,799,954 $1,220,082 $473,620 $2,262 $11,411,303
Brian Goff 2019 $740,000 - $3,863,694 - $923,076 $20,240 $5,547,010
Brian Goff 2018 $695,250 - $3,096,323 - $973,350 $111,873 $4,876,796
Brian Goff 2017 $381,634 $100,000 $2,390,026 $732,899 $434,380 $58,787 $4,097,726
Anne-Marie Law 2019 $695,000 - $3,622,303 - $788,130 $33,528 $5,138,961
Anne-Marie Law 2018 $650,000 - $2,889,885 - $910,000 $846,604 $5,296,489
Anne-Marie Law 2017 $362,500 $200,000 $2,300,015 - $410,472 $68,710 $3,341,697
John Orloff 2019 $770,000 - $3,863,694 - $960,498 $32,550 $5,626,742
John Orloff 2018 $695,250 - $3,096,323 - $973,350 $98,679 $4,863,602
John Orloff 2017 $376,442 $200,000 $2,499,995 - $472,500 $80,351 $3,629,288
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm

What are Alexion Pharmaceuticals Inc's Past Insider Trades?

Alexion Pharmaceuticals Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director,  Stephen Squinto, EVP,  and Vikas Sinha, EVP & CFO .

ALEXION PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1